US 12054493
Hepatitis B antiviral agents
granted A61KA61K31/167A61K31/18
Quick answer
US patent 12054493 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/167, A61K31/18, A61K31/196, A61K31/215